Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 4:50 pm Purchase |
2024-03-24 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,991 47.700% |
1,486,991 (New Position) |
Filing History |
| 2024-04-10 4:50 pm Purchase |
2024-03-24 | 13D | Landos Biopharma, Inc. LABP |
Xontogeny LLC | 309,092 9.900% |
309,092 (New Position) |
Filing History |
| 2024-02-14 4:01 pm Sale |
2023-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 0 0.000% |
-572,087 (Position Closed) |
Filing History |
| 2023-03-30 5:27 pm Unchanged |
2023-03-23 | 13D | Landos Biopharma, Inc. LABP |
Xontogeny LLC | 309,092 9.900% |
0 (Unchanged) |
Filing History |
| 2023-03-30 4:44 pm Unchanged |
2023-03-23 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,992 47.700% |
0 (Unchanged) |
Filing History |
| 2023-02-14 5:00 pm Sale |
2022-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 572,087 14.200% |
-65,000 (-10.20%) |
Filing History |
| 2023-01-13 5:07 pm Unchanged |
2023-01-10 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% |
0 (Unchanged) |
Filing History |
| 2022-11-03 4:15 pm Sale |
2022-11-01 | 13D | Landos Biopharma, Inc. LABP |
RTW Investments, LP | 0 0.000% |
-315,072 (Position Closed) |
Filing History |
| 2022-10-31 5:05 pm Sale |
2022-10-27 | 13D | Landos Biopharma, Inc. LABP |
RTW Investments, LP | 315,072 7.830% |
-50,000 (-13.70%) |
Filing History |
| 2022-10-06 4:30 pm Sale |
2022-10-04 | 13D | Landos Biopharma, Inc. LABP |
RTW Investments, LP | 365,072 9.070% |
-62,500 (-14.62%) |
Filing History |
| 2022-08-09 09:19 am Purchase |
2022-08-09 | 13D | Landos Biopharma, Inc. LABP |
Xontogeny LLC | 309,092 7.700% |
309,092 (New Position) |
Filing History |
| 2022-08-09 09:15 am Sale |
2022-08-09 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% |
-309,092 (-17.21%) |
Filing History |
| 2022-02-14 5:00 pm Purchase |
2021-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 637,087 15.800% |
637,087 (New Position) |
Filing History |
| 2022-02-03 4:49 pm Purchase |
2021-12-31 | 13G | Landos Biopharma, Inc. LABP |
Osage University GP III LLC | 182,748 4.500% |
182,748 (New Position) |
Filing History |
| 2021-04-06 5:00 pm Unchanged |
2021-03-31 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,796,084 44.800% |
0 (Unchanged) |
Filing History |
| 2021-02-18 5:15 pm Purchase |
2021-02-08 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,796,084 45.900% |
1,796,084 (New Position) |
Filing History |
| 2021-02-16 5:23 pm Purchase |
2021-02-04 | 13D | Landos Biopharma, Inc. LABP |
RTW Investments, LP | 427,572 10.660% |
427,572 (New Position) |
Filing History |